The latest closing stock price for BioNexus Gene Lab as of July 18, 2025 is 5.10.
An investor who bought $1,000 worth of BioNexus Gene Lab stock at the IPO in 2020 would have $1,242,902 today, roughly 1,243 times their original investment - a 315.87% compound annual growth rate over 5 years.
The all-time high BioNexus Gene Lab stock closing price was 285.60 on March 03, 2021.
The BioNexus Gene Lab 52-week high stock price is 15.60, which is 205.9% above the current share price.
The BioNexus Gene Lab 52-week low stock price is 2.01, which is 60.6% below the current share price.
The average BioNexus Gene Lab stock price for the last 52 weeks is 3.60.
An investor who bought $1,000 worth of BioNexus Gene Lab stock at the IPO in 2020 would have $1,242,902 today, roughly 1,243 times their original investment - a 315.87% compound annual growth rate over 5 years.
The all-time high BioNexus Gene Lab stock closing price was 285.60 on March 03, 2021.
The BioNexus Gene Lab 52-week high stock price is 15.60, which is 205.9% above the current share price.
The BioNexus Gene Lab 52-week low stock price is 2.01, which is 60.6% below the current share price.
The average BioNexus Gene Lab stock price for the last 52 weeks is 3.60.